Biologics: Development & Drug Substance Manufacturing

A worldwide network of pharmaceutical facilities offers a full continuum of services spanning early development through commercial supply. Capabilities include biologics production, small‑molecule API manufacturing, oral solid dose technologies, aseptic fill‑finish for vials and prefilled syringes, hot melt extrusion for complex formulations, and specialized support for antibody‑drug conjugates and ophthalmic products. Teams with extensive scientific and regulatory expertise guide programs through formulation, analytical development, process optimization, scale‑up, validation, and global launch. Facilities across multiple regions provide a range of scales, advanced containment options, and both single‑use and stainless‑steel systems to accommodate varying project needs. Integrated quality systems, dedicated project management, and flexible capacity help streamline timelines, mitigate risk, and ensure reliable supply from clinical phases through commercial production. The result is a comprehensive, end‑to‑end pathway designed to support complex drug programs with consistency, quality, and operational excellence.